Published in J Exp Med on October 01, 1971
A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. J Exp Med (1973) 5.55
Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01
Studies on the mechanism of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes. J Exp Med (1976) 3.30
Identification of human B and T lymphocytes by scanning electron microscopy. J Exp Med (1973) 3.21
Mouse thymus-independent and thymus-derived lymphoid cells. I. Immunofluorescent and functional studies. J Exp Med (1972) 2.96
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55
Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50
Idiotypic determinants of immunoglobulin M detected on the surface of human lymphocytes by cytotoxicity assays. J Exp Med (1972) 2.47
Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera. J Exp Med (1972) 1.64
Mesenteric lymph node B lymphoblasts which home to the small intestine are precommitted to IgA synthesis. J Exp Med (1977) 1.63
Regulation of the immune response. II. Qualitative and quantitative differences between thymus- and bone marrow-derived lymphocytes in the recognition of antigen. J Exp Med (1973) 1.57
Genetic control of the immune response. Frequency and characteristics of antigen-binding cells in high and low responder mice. J Exp Med (1973) 1.55
Immunoglobulin molecules on the surface of activated T lymphocytes in the rat. J Exp Med (1973) 1.53
Anatomical distribution of T and B lymphocytes in the rat. Development of lymphocyte-specific antisera. J Exp Med (1973) 1.44
Variation in accessible cell surface immunoglobulin among antibody-firming cells. J Exp Med (1972) 1.44
Requirements for prolonged suppression of an idiotypic specificity in adult mice. J Exp Med (1973) 1.38
Immunologic reactions to haptens on autologous carriers. I. Participation of both thymus-derived and bone marrow-derived cells in the secondary in vitro response. J Exp Med (1973) 1.36
Binding of thymus- and bone marrow-derived lymphoid cells to antigen-derivatized fibers. Proc Natl Acad Sci U S A (1972) 1.31
Lymphocyte activation. IV. The ultrastructural pattern of the response of mouse T and B cells to mitogenic stimulation in vitro. Immunology (1973) 1.29
Classification of thymus-derived and marrow-derived lymphocytes by demonstration of their antigen-binding characteristics. J Exp Med (1972) 1.27
Immunoglobulin synthesis and secretion by cells in the mouse thymus that do not bear theta antigen. Proc Natl Acad Sci U S A (1973) 1.24
Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants. J Exp Med (1973) 1.22
Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system. Proc Natl Acad Sci U S A (1972) 1.20
Age-decrease of cells sensitive to an autoantibody-specific for thymocytes and thymus-dependent lymphocytes in NZB mice. Clin Exp Immunol (1972) 1.14
Rosette-forming cells and the immunological response after DNCB, DNP-carrier and oxazolone sensitization. Immunology (1974) 1.12
Murine intestinal antibody response to heterologous rotavirus infection. J Clin Microbiol (1991) 1.11
A scanning and transmission electron microscope study of antigen-binding sites on rosette-forming cells. J Exp Med (1973) 1.10
Immunocompetent cells of the chicken. I. Specific surface antigenic markers on bursa and thymus cells. J Exp Med (1971) 1.08
2,4-Dinitrophenyl receptors on mouse thymus and spleen cells. J Exp Med (1973) 1.07
Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia. J Exp Med (1977) 1.05
Identification of mouse T and B lymphocytes from cytocentrifuged cell smears. Clin Exp Immunol (1976) 1.01
Theta antigen and immunogolbulin on a tissue-cultured mouse lymphoma. Immunology (1973) 1.01
Characterisation of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis (1981) 0.99
Escape from isoantiserum inhibition of lymphocyte-mediated cytotoxicity. J Exp Med (1973) 0.98
Responses of guinea-pig lymphocytes to mitogens, an antigen, and mixed leucocyte culture in media with and without mercaptoethanol and foetal calf serum. Immunology (1975) 0.98
Splenic replenishment of synergistic ability to bone marrow and thymic cells of neonatally splenectomized CBA mice. J Exp Med (1972) 0.97
Endotoxin-induced serum factor controlling differentiation of bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A (1977) 0.96
Spontaneous release of T-cell receptors for alloantigens. I. Recognition of alloantigens and receptor release dynamics. J Exp Med (1974) 0.87
Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells. Immunology (1976) 0.86
Cross-tolerance between serologically non-cross-reacting forms of egg white lysozyme. J Exp Med (1972) 0.86
Surface antigens of immunocompetent cells. 3. In vitro studies of the role of B and T cells in immunological memory. J Exp Med (1972) 0.84
RRBC and EAC rosette formation after DNCB contact sensitization and cyclophosphamide treatment of guinea-pigs. Immunology (1975) 0.83
Antigenic characterization of murine rosette and plaque-forming cells. Immunology (1973) 0.82
Heteroantisera prepared against B lymphocytes at different stages of differentiation. I. Preparation of sera and cytotoxicity to lymphoid cells from different organs. Immunology (1977) 0.81
Ultrastructural and serological studies on the resistance of activated B cells to the cytotoxic effects of anti-immunoglobulin serum. Patch and cap formation of surface immunoglobulin on mitotic B lymphocytes. Clin Exp Immunol (1975) 0.80
Thymus immunoglobulin receptors. Ontogenic development, response to antigenic stimulation and their possible role in the regulation of "aggressive" immune reactions. Immunology (1974) 0.80
Role of amino groups in formation of human lymphocyte-xenogeneic erythrocyte rosettes; a proposed mechanism for antigen recognition. Proc Natl Acad Sci U S A (1975) 0.80
C3 receptors on direct plaque-forming cells. Immunology (1975) 0.79
Cell surface antigens: invaluable landmarks reflecting the nature of cells. Cancer Immun (2012) 0.75
Studies on membrane-bound receptors for antigen. Preparation of populations of receptor-depleted lymphocytes. J Exp Med (1973) 0.75
Changes in the population and functional properties of antigen-specific rosette-forming B cells in antigen-primed mice by administration of polyclonal B-cell activator. Immunology (1978) 0.75
Non-specific and DNP--erythrocyte rosette formation after contact sensitization with DNCB. Immunology (1975) 0.75
THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES. J Exp Med (1964) 13.72
Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91
Thymus-marrow cell combinations. Synergism in antibody production. Proc Soc Exp Biol Med (1966) 10.03
STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM. J Exp Med (1965) 8.81
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Graft versus host reactions. Their natural history, and applicability as tools of research. Prog Allergy (1962) 7.11
Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency. Nature (1965) 6.84
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY. Methods Med Res (1964) 5.87
Surface alloantigens of plasma cells. J Exp Med (1970) 5.19
Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63
Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice. Proc Natl Acad Sci U S A (1971) 3.50
Biological effects of anti-immunoglobulins: evidence for immunoglobulin receptors on 'T' and 'B' lymphocytes. Transplant Rev (1970) 3.23
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Surface immunoglobulin-moieties on lymphoid cells. Exp Cell Res (1970) 2.09
Role of the thymus and other central lymphoid tissues in immunological disease. Annu Rev Med (1967) 1.76
Surface antigens of immunocompetent cells. I. Effect of theta and PC.1 alloantisera on the ability of spleen cells to transfer immune responses. J Exp Med (1970) 1.65
Anti-theta antibodies for detecting thymus-dependent lymphocytes in the immune response of mice to SRBC. Nature (1970) 1.61
Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16
A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96
Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98
Tumor necrosis factor (TNF). Science (1985) 8.80
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20
A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch (1989) 6.98
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45
Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pflugers Arch (1986) 6.15
The G (Gross) leukemia antigen. Cancer Res (1965) 6.07
The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains. Cell (1981) 5.43
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep (2001) 5.32
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21
Surface alloantigens of plasma cells. J Exp Med (1970) 5.19
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med (1976) 5.05
Lymphocytes as models for the study of mammalian cellular differentiation. Immunol Rev (1977) 5.01
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 4.66
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65
Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature (1975) 4.34
Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature (1986) 4.30
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. Proc Natl Acad Sci U S A (1979) 4.14
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A (1989) 4.13
Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Improved complementation in the cytotoxic test. Transplantation (1970) 3.93
Current enigmas in cancer research. Harvey Lect (1973) 3.91
Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A (1981) 3.72
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain (2007) 3.64
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res (1981) 3.62
Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A (1982) 3.58
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A (1968) 3.46
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43
Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. Transplantation (1971) 3.42
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42
Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. Transplantation (1972) 3.34
Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.31
In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes. Lancet (1973) 3.27
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27
Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A (1967) 3.26
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity (1994) 3.24
Recognition among mice. Evidence from the use of a Y-maze differentially scented by congenic mice of different major histocompatibility types. J Exp Med (1979) 3.23
Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology (1969) 3.21
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene (2007) 3.11
CBP as a transcriptional coactivator of c-Myb. Genes Dev (1996) 3.09
Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci (1995) 3.08
Safe right subclavian vein puncture: the importance of pressing the skin with the left thumb. Am J Emerg Med (1993) 3.07
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem (1999) 2.99
Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. J Exp Med (1976) 2.99